CVR: 44083205
Secondary names: Serprozyme Pharmaceuticals Aps, Serprozyme Bio ApS, Serprozyme Danmark ApS
DKK 168,506
Gross profit
Net result: DKK 131,445
Emvijo Initiative ApS, Jan Kristian Jensen Holding ApS
CVR · view ownership and management
Director registered: Jan Kristian Jensen
CVR · 26/05/2023
View the full event history
Serprozyme ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kristian Jensen. The company is owned by Emvijo Initiative ApS and Jan Kristian Jensen Holding ApS. In 2025, the company reported a gross profit of DKK 168,506 and a net result of DKK 131,445 compared with DKK 24,507 the year before. Equity in the 2025 report amounted to DKK 193,766.
Selskabets formål er at drive virksomhed med handel og service, samt enhver i forbindelse hermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorSerprozyme ApS was founded on 26 May 2023.
Serprozyme ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Serprozyme ApS is owned by Emvijo Initiative ApS and Jan Kristian Jensen Holding ApS.
In 2025, Serprozyme ApS reported a gross profit of DKK 168,506.
The management of Serprozyme ApS consists of Jan Kristian Jensen.
Serprozyme ApS is located at Ølstvadbrovej 31, 8940 Randers SV.
Claim this page to add your logo and social links. Free to get started.
Serprozyme ApS has published its annual report for 2025. Gross profit came to DKK 168,506, and the net result was DKK 131,445.
Serprozyme ApS has published its annual report for 2024. Gross profit came to DKK 31,033, and the net result was DKK 24,507.
Serprozyme ApS has published its interim report for the period May 26, 2023 – December 31, 2023.
As of May 26, 2023, Jan Kristian Jensen is registered as adm. dir. of Serprozyme ApS.
As of May 26, 2023, Emvijo Initiative ApS is registered as an owner of Serprozyme ApS with an ownership share of 50%.
As of May 26, 2023, Jan Kristian Jensen Holding ApS is registered as an owner of Serprozyme ApS with an ownership share of 50%.
Serprozyme ApS was founded on May 26, 2023.
Companies in the same industry and area
CVR 20110007
CVR 43257706
CVR 21826804
CVR 30521641
CVR 37493678
